51
|
|
|
RAB44, member RAS oncogene family |
RASD3, RASL13, dJ431A14.3 |
|
52
|
|
|
RAB4B, member RAS oncogene family |
- |
|
53
|
|
|
RAB5A, member RAS oncogene family |
RAB5 |
|
54
|
|
|
RAB5B, member RAS oncogene family |
- |
Anorexia nervosa, Asthma, Eczema, Autoimmune disease, Basal cell carcinoma, Gastroesophageal reflux disease, Hashimoto disease, Hypothyroidism, Nasal polyp, Peptic ulcer disease, Polycystic ovary syndrome, Psoriasis, Rheumatoid arthritis, Diabetes mellitus type 1, Diabetes mellitus type 2, Uterine fibroidView all (1 more) |
55
|
|
|
RAB5C, member RAS oncogene family |
L1880, RAB5CL, RAB5L, RABL |
|
56
|
|
|
RAB5 interacting factor |
C20orf24, CFSMR2, OPTI, PNAS-11, RCAF1, RIP5 |
Breast cancer, Cancer, Cleft palate and bilateral cleft lip, Colorectal cancer, Congenital fusion of ribs, Craniofacial dysmorphism skeletal anomalies intellectual disability syndrome, Estrogen-receptor negative breast cancer, Intellectual developmental disorder, Lung cancer, Melanoma, Micrognathism, Ovarian cancer, Ovarian serous carcinoma, Prostate cancer, Scoliosis, Squamous cell carcinomaView all (1 more) |
57
|
|
|
RAB6A, member RAS oncogene family |
RAB6 |
|
58
|
|
|
RAB7A, member RAS oncogene family |
CMT2B, PRO2706, RAB7 |
|
59
|
|
|
RAB7B, member RAS oncogene family |
RAB7 |
|
60
|
|
|
RAB8A, member RAS oncogene family |
MEL, RAB8 |
|